Literature DB >> 24455524

Composite pheochromocytoma.

Rakesh Rai1, Suhitha Gajanthody1, Jnaneshwari Jayaram1, Rajeev Kumar Chaudhry1.   

Abstract

Entities:  

Year:  2012        PMID: 24455524      PMCID: PMC3876607          DOI: 10.4103/2278-330X.103727

Source DB:  PubMed          Journal:  South Asian J Cancer        ISSN: 2278-330X


× No keyword cloud information.
Sir, Mixed adrenal tumors composed of more than one cell type are uncommon, and they are called composite pheochromocytomas[1] and corticomedullary mixed tumors.[2] Composite pheochromocytoma is a well-defined neoplasm of the medulla and the tumor consists of both endocrine and neural components. Histopathologically, the endocrine portion is that of a pheochromocytoma, whereas the neural portion has been reported as ganglioneuroma, ganglioneuroblastoma, neuroblastoma, neuroendocrine carcinoma, or malignant peripheral nerve sheath tumor.[3] Pheochromocytoma is usually characterized by a catecholaminergic effect with hypertension, whereas ganglioneuroma is a rare mature neuroblastic tumor that is typically non-metabolically active and so it is usually asymptomatic.[45] Here discussion is on an atypical case of 40-year-old female presenting with acute abdomen in the setting of undiagnosed huge pheochromocytoma. We also review the contribution of catecholamine hyper-secretion to patient’s symptomatology. A 40-year-old woman presented with complaints of abdominal pain and vomiting of 1-day duration. She was not a known hypertensive or diabetic. Hemogram reports revealed leukocytosis. Contrast enhanced computerized tomography (CECT) abdomen showed large multiseptated cystic lesion with hyper-dense solid appearing non-enhancing areas in the left suprarenal location suggestive of hemorrhagic left adrenal lesion [Figure 1a and b. In view of adrenal tumors, 24-h urine was further evaluated for the presence of vinyl mandelic acid (VMA), metanephrine, and normetanephrine.
Figure 1

a: Axial contrast-enhanced computed tomography (CECT) image of left adrenal tumor b: Coronal contrast-enhanced computed tomography (CECT) image of left adrenal tumor

a: Axial contrast-enhanced computed tomography (CECT) image of left adrenal tumor b: Coronal contrast-enhanced computed tomography (CECT) image of left adrenal tumor Lab values: Normetanephrine in urine: 900 μg/day (0-600 μg/d) Metanephrine: 40 μg/day (0-350 μg/day) VMA: 33 mg/day (upto 15 mg/day). Thus, a diagnosis of normetanephrine-secreting pheochromocytoma was made. Pre-operative management for adrenalectomy was carried out for 10 days and left adrenalectomy was done [Figure 2a and b. She was discharged in a stable condition on day 5 after operation.
Figure 2

(a) Intra operative: Around 20 × 18 cm large hemorrhagic lesion in the left suprarenal location, (b)Left adrenalectomy specimen

(a) Intra operative: Around 20 × 18 cm large hemorrhagic lesion in the left suprarenal location, (b)Left adrenalectomy specimen Histology revealed composite pheochromocytoma measuring 18 × 14 × 6 cm (pheochromocytoma + ganglioneuroma). Although pheochromocytoma may occur at multiple sites and in association with a number of other tumors, the presence of both pheochromocytoma and ganglioneuroma within a single tumor is extremely rare.[678] Although pheochromocytoma is a tumor that originated from the adrenal medullary chromaffin cells, ganglioneuroma represents a tumor from autonomic ganglion cells or their precursors. Embryologically, both chromaffin and ganglion cells are derived from neural crest cells and migrates to somatic areas.[9] The composite tumor has been used to describe tumors that theoretically arise from a common embryological progenitor, whereas mixed pheochromocytoma designate tumors have no common embryological ancestry.[10] In about 70% of composite adrenal medullary tumors, the accompanying second tumor component was ganlioneuroma.[11] It is apparent that a composite tumor of pheochromocytoma and ganglioneuroma may display symptoms referable to hormonal hyper-secretion by either portion of the tumor.[6] Clinically, active pheochromocytoma may produce the classic symptoms of headache, palpitations, and excessive perspiration in 50% of the cases. In addition, hypertension, either sustained or paroxysmal, is the cardinal feature of pheochromocytoma.[12] Occasional normotensive patients with composite tumor may be explained by the theory of autonomic regulation by ganglioneuroma and it partially depends on the complex biochemical interaction and proportion of each elements.[13] Both pheochromocytoma and ganglioneuroma commonly manifests radiologically as a well-defined smooth or lobulated mass with or without calcification. CT is accurate in detection of pheochromocytomas. Composite pheochromocytoma and ganglioneuroma show heterogenous radiological, gross, and microscopic features with varying admixtures of ganglioneuroma and pheochromocytoma components.[14] Composite pheochromocytomas are rare catecholamine-producing tumor which has the propensity to large size which is unlikely when it is classical pheochromocytoma. Clinical manifestations unique to the tumor are occasional and atypical and non-specific symptomatology and its association with autoimmune disorders. A multidisciplinary approach involving anesthesia, endocrinology, and surgical expertise is the gold standard in maximizing patient care.
  11 in total

Review 1.  [A compound tumor in the adrenal medulla--pheochromocytoma combined with ganglioneuroma: a case report].

Authors:  M Okumi; Y Matsuoka; M Tsukikawa; N Fujimoto; S Sagawa; K Itoh
Journal:  Hinyokika Kiyo       Date:  2000-12

2.  Composite phaeochromocytoma with malignant peripheral nerve sheath tumour and rhabdomyosarcomatous differentiation in a patient without von Recklinghausen disease.

Authors:  R Gupta; A Sharma; R Arora; M Vijayaraghavan
Journal:  J Clin Pathol       Date:  2009-07       Impact factor: 3.411

Review 3.  The migration and differentiation of neural crest cells.

Authors:  J A Weston
Journal:  Adv Morphog       Date:  1970

4.  Composite adrenal phaeochromocytoma-ganglioneuroma causing watery diarrhoea, hypokalaemia and achlorhydria syndrome.

Authors:  Deepu J George; Gill A Watermeyer; Dion Levin; David Epstein; Ian L Ross; Barbara U Scholz; Matshiko Setshedi; Michael Locketz; Cornelli Dittrich; John Shaw; Jake E Krige
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-05       Impact factor: 2.566

5.  Mixed cortical adenoma and composite pheochromocytoma-ganglioneuroma: an unusual corticomedullary tumor of the adrenal gland.

Authors:  Sean K Lau; Peiguo G Chu; Lawrence M Weiss
Journal:  Ann Diagn Pathol       Date:  2010-04-29       Impact factor: 2.090

Review 6.  Compound adrenal medullary tumor.

Authors:  P J Moore; P J Biggs
Journal:  South Med J       Date:  1995-04       Impact factor: 0.954

7.  Pheochromocytoma-ganglioneuroma of the adrenal.

Authors:  P J Kragel; C A Johnston
Journal:  Arch Pathol Lab Med       Date:  1985-05       Impact factor: 5.534

8.  Composite Pheochromocytoma-Ganglioneuroma of the Adrenal Gland: An Uncommon Entity with Distinctive Clinicopathologic Features.

Authors:  King-Yin Lam; Chung-Yau Lo
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

9.  Composite adrenal medullary tumor: A rare cause of hypertension in a young male.

Authors:  Santosh Menon; Pravin Mahajan; Sangeeta B Desai
Journal:  Urol Ann       Date:  2011-01

10.  A case of a composite adrenal medullary tumor of pheochromocytoma and ganglioneuroma masquerading as acute pancreatitis.

Authors:  Eun-Kyoung Choi; Wan-Ho Kim; Keun-Yong Park
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.